您至少选一个职位
职位描述
Major Responsibilities (Describe main activities) 1. Manage collection, processing, documentation, reporting and follow-up of all adverse events (AE) reports for all Novartis products from clinical trials, post-marketing studies (PMS), Spontaneous Reports (SR), registries, commercial programs, etc. 2. Ensure accurate and consistent transcription, translations and data entry of all Serious Adverse Events (SAE) from source documents onto safety systems (e.g. SINA, ARGUS, etc) with emphasis on timeliness and quality. 3. Ensure recording and tracking of receipts, submissions and distributions of SAEs, SRs, Investigator Notifications (IN), Periodic Safety Report Updates (PSUR). 4. Manage reporting/submission/distribution of safety reports/updates/information (e.g. SAE, SR, IN, PSUR, ASR) to Local Health Authority (LHA) and/or clinical operations. 5. Work with other local/global DS&E associates to ensure accurate evaluation of safety data. 6. Interact and exchange relevant safety information with Local Health Authority, other functional groups and third party contractor, if applicable. 7. Survey and monitor Chinese pharmacovigilance regulations and provide update to global DS&E organization. 8. Set up, update and implement local procedures to ensure compliance with DS&E global procedures and Chinese requirements. 9. Input, review and approval of program proposals for language, content and establishment of necessary controls on collection and reporting of adverse event information. 10. Assure reconciliation is performed with other departments (e.g. Medical Information, Quality Assurance, Customer Service Centre and third party contractor, if applicable) for potential AEs resulting from medical inquiries and quality related complaints. 11. Management and maintenance all relevant DS&E databases. 12. Ensure timely preparation and submission of KPI reports on AE reporting including identification of root cause(s) for late reporting to Local Health Authority, development and implementation of corrective action(s) as needed. 13. Develop and update training materials for pharmacovigilance and ensure training of CPO associates on relevant DS&E procedures for AE reporting, including field force and third party contractor, if applicable. 14. Ensure support for and close-out of audits, corrective action plan, investigation and Health Authority inspections. 15. Ensure training and oversight of staff, as applicable. 16. Manage and maintain efficient DS&E filing and archive system. 17. Ensure RMP implementation in PVO and coordination of RMP activities in CPO. Ideal Background Education: A degree in medicine, pharmacy, health discipline or life sciences Languages:Fluent in both written and spoken English Good working knowledge of Chinese
工作地点
北京 收起地图
诺华公司(nyse: nvs) 致力于维护健康,治疗疾病,提高生活品质,在全球制药行业居领先位置,2007年位居世界500强企业第168位。 1996年,瑞士莱茵河畔两家拥有百年历史的公司——汽巴-嘉基公司和山德士公司宣布合并,成立了诺华公司。在公司董事长兼首席执行官魏思乐博士(dr.daniel vasella)的领导下,诺华公司不断发展,十年来保持强劲增长,为全球的医药保健领域作出了巨大贡献。 诺华专注于医药保健的增长领域,拥有创新药品、质优价廉型非专利药品、预防性疫苗和诊断试剂,以及消费者保健产品等多元化的业务组合,以此最好地满足患者和社会的需求。诺华是唯一在上述四大领域均处于领先位置的公司。 2007年,诺华集团实现净销售398亿美元,净收入120亿美元。集团研发投入约为64亿美元。诺华公司总部位于瑞士巴塞尔,在全球拥有98,000名员工,业务遍及世界140多个国家。 仅2007年一年中,诺华的药品和疫苗就用于治疗和预防世界上8亿人的疾病。 诺华源于拉丁文novae artes,意为“新技术”。公司的中文名字——诺华,取意承诺中华,即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。
@2008-2020 大街网 京ICP备09028813号-1 人才服务许可证:1101052019005号 京公网安备11010502035247 京ICP证090373号
北京大杰致远信息技术有限公司 公司地址:北京市海淀区成府路28号优盛大厦D座18层1801 联系方式:010-53935585-8826